146 related articles for article (PubMed ID: 7767963)
1. The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgene.
Zaidi NH; Allay E; Ayi TC; Li BF; Dumenco LL; Sy MS; Gerson SL
Carcinogenesis; 1995 May; 16(5):1047-53. PubMed ID: 7767963
[TBL] [Abstract][Full Text] [Related]
2. Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas.
Liu L; Allay E; Dumenco LL; Gerson SL
Cancer Res; 1994 Sep; 54(17):4648-52. PubMed ID: 8062258
[TBL] [Abstract][Full Text] [Related]
3. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
Allay E; Veigl M; Gerson SL
Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis.
Qin X; Zhou H; Liu L; Gerson SL
Carcinogenesis; 1999 Sep; 20(9):1667-73. PubMed ID: 10469609
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferase.
Allay E; Reese JS; McGuire EA; Koç ON; Sedransk N; Gerson SL
Oncogene; 1997 Oct; 15(17):2127-32. PubMed ID: 9366529
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
Reese JS; Allay E; Gerson SL
Oncogene; 2001 Aug; 20(38):5258-63. PubMed ID: 11536039
[TBL] [Abstract][Full Text] [Related]
7. Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT.
Qin X; Liu L; Gerson SL
Oncogene; 1999 Jul; 18(30):4394-400. PubMed ID: 10439048
[TBL] [Abstract][Full Text] [Related]
8. Alkyltransferase transgenic mice: probes of chemical carcinogenesis.
Gerson SL; Zaidi NH; Dumenco LL; Allay E; Fan CY; Liu L; O'Connor PJ
Mutat Res; 1994 Jun; 307(2):541-55. PubMed ID: 7514728
[TBL] [Abstract][Full Text] [Related]
9. N-methyl-N-nitrosourea alters thymocyte subset distribution and targets immature CD4-8+ cells for lymphoma development.
Stettner SL; Rummel SA; Conti CJ; Richie ER
Cancer Res; 1991 Jan; 51(2):737-40. PubMed ID: 1898715
[TBL] [Abstract][Full Text] [Related]
10. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice.
Sakumi K; Shiraishi A; Shimizu S; Tsuzuki T; Ishikawa T; Sekiguchi M
Cancer Res; 1997 Jun; 57(12):2415-8. PubMed ID: 9192819
[TBL] [Abstract][Full Text] [Related]
11. The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase.
Dumenco LL; Allay E; Norton K; Gerson SL
Science; 1993 Jan; 259(5092):219-22. PubMed ID: 8421782
[TBL] [Abstract][Full Text] [Related]
12. Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis.
Becker K; Dosch J; Gregel CM; Martin BA; Kaina B
Cancer Res; 1996 Jul; 56(14):3244-9. PubMed ID: 8764116
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of thymic lymphosarcoma induced by N-methyl-N-nitrosourea in C57B1/6J mice.
Frank AA; Collier JM; Forsyth CA; Oughton JA; Kerkvliet NI
Carcinogenesis; 1992 Mar; 13(3):509-12. PubMed ID: 1547544
[TBL] [Abstract][Full Text] [Related]
14. Low expression of the Lsp1 gene in early mouse T-lymphomas induced by N-methyl-N-nitrosourea.
Brennan L; Jongstra J
Carcinogenesis; 1996 Apr; 17(4):771-7. PubMed ID: 8625490
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characterization of thymic prelymphoma cells of B10 mice treated with split-dose irradiation.
Muto M; Kubo E; Kamisaku H; Sado T
J Immunol; 1990 Feb; 144(3):849-53. PubMed ID: 2104913
[TBL] [Abstract][Full Text] [Related]
16. Influence of murine leukemia proviral integrations on development of N-methyl-N-nitrosourea-induced thymic lymphomas in AKR mice.
Richie ER; Angel JM; Cloyd MW
J Virol; 1991 Nov; 65(11):5751-6. PubMed ID: 1656068
[TBL] [Abstract][Full Text] [Related]
17. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice.
Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M
Carcinogenesis; 2000 Feb; 21(2):301-5. PubMed ID: 10657972
[TBL] [Abstract][Full Text] [Related]
18. Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents.
Kaina B; Fritz G; Mitra S; Coquerelle T
Carcinogenesis; 1991 Oct; 12(10):1857-67. PubMed ID: 1657427
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic and mutagenic effects of methylnitrosourea in two human fetal fibroblast strains differing in O6-methylguanine-DNA methyltransferase activity.
Mirzayans R; Middlestadt MV; Paterson MC
Carcinogenesis; 1992 Jul; 13(7):1185-90. PubMed ID: 1638685
[TBL] [Abstract][Full Text] [Related]
20. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
Mangues R; Kahn JM; Seidman I; Pellicer A
Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
